RPG Life Sciences Limited (RPGLIFE) — Financial Results | 8 May 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

RPG Life Sciences Limited announced the transcript of its Q4 FY26 earnings call held on March 30, 2026, at 3:30 p.m. IST, now available on its website for investors to access and disseminate.

📄 View Original Announcement (PDF)

About RPG Life Sciences Limited (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,456.85 Cr P/E: 37.3 ROE: 19.8% ROCE: 25.8% Div Yield: 0.89%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

📊 More RPGLIFE filings

See all RPGLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day